Form 4: Align Technology CFO Reports Equity Transactions

Align Technology's CFO, John Morici, reported routine equity transactions including new RSU and MSU grants, vesting of prior awards, and share disposals for tax withholding.

Summary

• John Morici, EVP, Chief Financial Officer of Align Technology, Inc. (ALGN), reported several equity transactions on February 20, 2026.
• Acquired 7,848 shares of Common Stock at a price of $0, likely due to the exercise or vesting of derivative securities.
• Disposed of 2,549 shares of Common Stock at a price of $190.02, typically for tax withholding purposes related to equity vesting.
• Beneficial ownership of Common Stock following these transactions is 13,536 shares.
• Received a new grant of 8,423 Restricted Stock Units (RSUs) with a par value of $0.0001, vesting 1/4th annually starting February 20, 2027.
• Received a new grant of 17,102 Market Stock Units (MSUs) with a par value of $0.0001, which may vest at target or up to 250% if performance exceeds target, on the last day of the third year of the Performance Period.
• Several previously granted RSUs and MSUs vested and shares were delivered on February 20, 2026, including 837 units from a 2024 RSU grant, 1,251 units from a 2025 RSU grant, 389 units from a 2022 RSU grant, 4,653 units from a 2023 MSU grant, and 718 units from a 2023 RSU grant.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing. While routine, the new grants of RSUs and MSUs indicate continued executive alignment with shareholder interests and long-term company performance, which is a positive signal for governance and retention.

Positives

• The grant of 8,423 new Restricted Stock Units (RSUs) and 17,102 new Market Stock Units (MSUs) aligns the CFO's interests with long-term company performance.
• Vesting of prior equity awards demonstrates the ongoing compensation structure for executive management.

Negatives

• Disposal of 2,549 shares of Common Stock for tax withholding purposes reduces the CFO's direct shareholding, though this is a standard practice for equity compensation.

Future Outlook

The newly granted Restricted Stock Units (RSUs) will vest annually in 1/4th increments starting February 20, 2027. The Market Stock Units (MSUs) granted on February 20, 2026, will vest on the last day of the third year of their Performance Period, with the potential for higher share delivery if performance targets are exceeded.

Industry Context

StockSavvy.ai notes that these transactions are typical for executive compensation packages in the medical device and technology sectors, where equity awards are a common tool for long-term incentive and retention.

Stakeholder Impact

• Shareholders: The new equity grants align executive incentives with long-term shareholder value creation. The disposal of shares for tax purposes represents minor, routine dilution.
• Employees: Reflects standard executive compensation practices, which can influence broader compensation strategies within the company.

Next Steps

• Annual vesting of the 8,423 Restricted Stock Units granted on February 20, 2026, will commence on February 20, 2027.
• Vesting of the 17,102 Market Stock Units granted on February 20, 2026, will occur on the last day of the third year of the Performance Period.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation and tax-related transactions. It does not contain new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The transactions are expected and reflect standard corporate governance practices for executive equity awards.

Keywords

ALGN, Align Technology, Form 4, Insider Transaction, Equity Compensation, Restricted Stock Unit, Market Stock Unit, Executive Compensation, Stock Vesting, Share Disposal